Teachers Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Teachers Advisors’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$94K	Hold	96,473	–	–	﹤0.01%	2940
2018 Q4	$71K	Hold	96,473	–	–	﹤0.01%	2974
2018 Q3	$208K	Sell	96,473 -1,021	-1%	-$2.53K	﹤0.01%	2933
2018 Q2	$486K	Buy	+97,494	New	+$427K	﹤0.01%	2664
2016 Q1	–	Sell	-24,752	Closed	-$304K	–	3125
2015 Q4	$304K	Sell	24,752 -81,673	-77%	-$1.09M	﹤0.01%	2701
2015 Q3	$1.55M	Hold	106,425	–	–	﹤0.01%	1730
2015 Q2	$2.08M	Buy	106,425 +4,751	+5%	+$91.7K	﹤0.01%	1665
2015 Q1	$1.84M	Buy	101,674 +18,729	+23%	+$422K	﹤0.01%	1701
2014 Q4	$1.96M	Hold	82,945	–	–	﹤0.01%	1653
2014 Q3	$2.01M	Hold	82,945	–	–	﹤0.01%	1591
2014 Q2	$2.33M	Buy	82,945 +64,068	+339%	+$1.93M	﹤0.01%	1521
2014 Q1	$642K	Buy	18,877 +2,290	+14%	+$78.3K	﹤0.01%	2261
2013 Q4	$318K	Hold	16,587	–	–	﹤0.01%	2634
2013 Q3	$272K	Buy	16,587 +2,318	+16%	+$26.9K	﹤0.01%	2663
2013 Q2	$150K	Buy	+14,269	New	+$167K	﹤0.01%	2908

Other funds holding CTIC

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Teachers Advisors's CTIC Position: Q1 2019 in Review

Teachers Advisors held its CTI BioPharma Corp. (DE) Common Stock (CTIC) position steady in Q1 2019 at 96,473 shares worth $94K. The position accounts for ﹤0.01% of the portfolio, ranked #2940.

Teachers Advisors first reported a position in CTIC in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.33M in Q2 2014. 67 funds tracked by Wall St. Rank hold CTIC as of Q1 2019.

Teachers Advisors held 96,473 shares of CTI BioPharma Corp. (DE) Common Stock worth $94K as of Q1 2019.
Teachers Advisors left its CTI BioPharma Corp. (DE) Common Stock share count unchanged in Q1 2019.
CTI BioPharma Corp. (DE) Common Stock made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2940 holding.
Teachers Advisors first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and has held it in 15 quarters since.
Teachers Advisors's CTI BioPharma Corp. (DE) Common Stock position peaked at $2.33M in Q2 2014.
67 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.